| ACE-2 | angiotensin-converting enzyme 2 |
| AKI | acute kidney injury |
| Akt | protein kinase B (PKB/AKT) |
| CD | Cluster differentiation |
| CKD | chronic kidney disease |
| CNI | Calcineurin inhibitors |
| COVID-19 | coronavirus 19 disease |
| eGFR | estimated glomerular filtration rate |
| EPO | Erythropoietin |
| ESRD | end stage renal disease. |
| GN | glomerulonephritis |
| HD | hemodialysis |
| KT | kidney transplantation |
| MPA | Mycophenolic acid |
| mTOR | mechanistic target of rapamycin |
| NF-kB | nuclear factor kappa-light-chain-enhancer of activated B cells |
| PI3K | phosphatidylinositol 3-kinase |
| RAAS | renin-angiogenin-aldosterone system |
| SARS-CoV-2 | severe acute respiratory syndrome coronavirus 2 |